
BPEA Private Equity, registered with the SEC as Brooke Private Equity Associates Management LLC, is a private-equity investment adviser headquartered in Boston, Massachusetts. Established in 2002, it advises private funds and provides customized investment programs focused on small and lower-middle-market buyout and growth investing. Its platform pairs commitments to private-equity funds with direct co-investments in companies and includes dedicated healthcare programs. SEC records show that its registration became effective in 2012, adding a public regulatory history to more than two decades of operations. Private equity is its primary asset class. Its programs include diversified fund-of-funds vehicles with direct co-investment allocations, small-market buyout and growth, healthcare-focused investments, and customized separate accounts for institutional investors. BPEA Private Equity exercises investment discretion subject to each fund’s objectives and guidelines; its process includes manager and direct-investment diligence, selection, and post-investment monitoring. The small buyout and growth mandate centers on profitable U.S. businesses, while customized programs may have global or regional mandates and healthcare programs are diversified across geographies. Sector interests include business services and software, healthcare, consumer and retail, and industrials. Advisory clients are generally private limited partnerships or other funds; investors in those vehicles typically include high-net-worth individuals, trusts, pension plans, corporations, endowments, and foundations. The latest Form ADV reports 19 employees and identifies Boston as the principal office. BPEA Private Equity combines fund selection and direct private-company investing with tailored programs for a mix of institutional and individual capital providers.